Skip to main content
Fig. 2 | Genome Medicine

Fig. 2

From: Longitudinal analysis of the peripheral B cell repertoire reveals unique effects of immunization with a new influenza virus strain

Fig. 2

Vaccination with TIV induced homotypic seroconversion (a), while 09 MIV induced heterotypic seroconversion against pre-pandemic H1N1 (b). Homotypic and heterotypic seroconversion rates for vaccination with TIV and 09 MIV. TIV showed low seroconversion rates for vaccine strains due to pre-exposure (high pre-vaccination titers) (n = 6). The 09 MIV vaccine had a higher homotypic seroconversion (83 % and 75 %) and heterotypic seroconversion against 2008 H1N1 in 17 % of the immunized participants (n = 23) (arrow)

Back to article page